Expertise in
11
conditions

Dr. Christine E. Codding

Rheumatology
1211 N. Shartel Ave., Ste 700, 
Oklahoma City, OK 
Accepting New Patients
Referral may be required
Before you request
Expertise in
11
conditions
1211 N. Shartel Ave., Ste 700, 
Oklahoma City, OK 

Overview

Christine Codding is a Rheumatologist practicing medicine in Oklahoma City, Oklahoma.

Dr. Codding is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Palindromic Rheumatism, Psoriatic Arthritis, and Ankylosing Spondylitis.

Dr. Codding is board certified in Drug Enforcement Administration , Oklahoma State Board Of Medical Licensure & Supervision, and Oklahoma Bureau Of Narcotics And Dangerous Drugs . She is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 8 clinical trials. Dr. Codding is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in OK

Board Certifications

Drug Enforcement Administration
Oklahoma State Board Of Medical Licensure & Supervision
Oklahoma Bureau Of Narcotics And Dangerous Drugs

Fellowships

Oklahoma University Health Science Center

Hospital Affiliations

SSM Health St. Anthony Hospital - Midwest
SSM Health St. Anthony Hospital - Oklahoma City
Norman Regional
Community Hospital, LLC
Ssm Health St Anthony Hospital - Oklahoma City
Ssm Health St Anthony Hospital - Shawnee
Integris Canadian Valley Hospital

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
CommunityCare
  • HMO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

1211 N. Shartel Ave., Ste 700, Oklahoma City, OK 73103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Enrollment Status: Active_not_recruiting
Publish Date: April 14, 2026
Intervention Type: Procedure, Device, Drug
Study Drug: Conventional Synthetic DMARD
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Study to Evaluate the Efficacy and Safety of LY3462817 in Participants With Moderately to Severely Active Rheumatoid Arthritis
A Phase 2 Study to Evaluate the Efficacy and Safety of LY3462817 in Participants With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 12, 2023
Intervention Type: Drug
Study Drug: LY3462817
Study Phase: Phase 2
View 6 Less Clinical Trials

6 Total Publications

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.
Journal: Rheumatology and therapy
Published: April 03, 2019
Similar Doctors
Expertise in
6
conditions
Dr. Ira N. Targoff
Rheumatology
Expertise in
6
conditions
Dr. Ira N. Targoff
Rheumatology
Referral may be required
Before you request

Ou Health Physicians-Internal Medicine Clinic

1000 NE 13th St # 1G, 
Oklahoma City, OK 
 (1.3 miles away)
572-244-0063
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ira Targoff is a Rheumatologist practicing medicine in Oklahoma City, Oklahoma. Dr. Targoff is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Juvenile Dermatomyositis, Polymyositis, and Myositis. Dr. Targoff is currently accepting new patients.

Expertise in
20
conditions
Dr. Craig W. Carson
Rheumatology
Expertise in
20
conditions
Dr. Craig W. Carson
Rheumatology
Referral may be required

Oklahoma Arthritis Center PC

1701 Renaissance Blvd Ste 110, 
Edmond, OK 
 (9.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Craig Carson is a Rheumatologist practicing medicine in Edmond, Oklahoma. Dr. Carson is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis. Dr. Carson is currently accepting new patients.

Expertise in
3
conditions
Expertise in
3
conditions
Referral may be required

Oklahoma Medical Research Foundation

825 N.E. 13th St., 
Oklahoma City, OK 
 (1.6 miles away)
405-271-6242
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Board certified in internal medicine and rheumatology, Cristina Arriens, MD serves SSM Health St. Anthony patients in the Oklahoma City metro area at the Oklahoma Medical Research Foundation. As a rheumatologist, she specializes in conditions such as arthritis and autoimmune diseases, among others. She has participated in extensive research in arthritis and clinical immunology, including but not limited to research on systemic lupus erythematosus and various potential treatments. Dr. Arriens is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Arthritis, and Rheumatoid Arthritis (RA). Dr. Arriens is board certified in American Board Of Internal Medicine/Rheumatology , Oklahoma State Board Of Medical Licensure & Supervision, Drug Enforcement Administration , and Oklahoma Bureau Of Narcotics And Dangerous Drugs . Dr. Arriens is currently accepting new patients.

Frequently Asked Questions about Dr. Christine E. Codding

How do I make an appointment with Dr. Christine E. Codding?

You can book an appointment with Dr. Christine E. Codding by calling their office at 405-702-6700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christine E. Codding a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christine E. Codding is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christine E. Codding specialize in?

While Dr. Christine E. Codding is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Palindromic Rheumatism, and Psoriatic Arthritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Christine E. Codding participate in research or clinical trials?

Yes. Dr. Christine E. Codding has published 6 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Christine E. Codding's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christine E. Codding accept my insurance?

Dr. Christine E. Codding accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 405-702-6700 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Codding's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile